Shield Therapeutics drops as CFO exits and Medicaid concerns weigh

Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) fell 12% to 7.71p after the group reported first-quarter revenue growth and positive earnings but...